Search | Page 7 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Strong results for SAA patients at Johns Hopkins

    ... and an author of the report. Results of the small clinical trial have already prompted the organization of a larger national trial ...

    Article last updated 02/07/2017 - 11:05am.

  2. Low Dose Danazol for the Treatment of Telomere Related Diseases

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... the efficacy, appropriateness or suitability of any clinical trial listed on this website. Pharmaceutical company sponsored ...

    Clinical Trial last updated 05/31/2018 - 2:53pm.

  3. Outcome of patients treated for myelodysplastic syndromes without deletion 5q after failure of lenalidomide therapy

    ... remains relatively prolonged, though with a wide range. Clinical trial participation remains the recommendation for these patients even if ...

    Research Article last updated 02/21/2017 - 9:43am.

  4. Oncologists tell the backstory of informed consent

    ... worsens in medical research. Before you can enroll in a clinical trial of a cancer drug, we’ll hand you a 25-page document that describes ...

    Article last updated 03/02/2017 - 10:03am.

  5. Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher risk myelodysplastic syndromes

    ... A phase 2 randomized, placebo -controlled clinical trial of azacitidine and pracinostat was conducted in patients who had ...

    Research Article last updated 02/03/2017 - 11:12am.

  6. Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromes

    ... randomized trials. The two drugs have not been compared in clinical trials. We identified patients diagnosed with MDS between 2004 and ... was substantially shorter than in the AZA-001 clinical trial (11 versus 24·5 months). ...

    Research Article last updated 10/06/2016 - 11:34am.

  7. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.

    ... in older patients who are often treated outside the clinical trial setting. Consequently, our understanding of the patterns of ...

    Research Article last updated 09/19/2016 - 11:05am.

  8. A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients with Myelodysplastic Syndrome (MDS)

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... Purpose:  The goal of this clinical research study is to learn if azacitidine in combination ...

    Clinical Trial last updated 05/14/2018 - 1:57pm.

  9. Design and rationale of the QUAZAR Lower-Risk MDS (AZA-MDS-003) trial: a randomized phase 3 study of CC-486 (oral azacitidine) plus best supportive care vs placebo plus best supportive care in patients with IPSS lower-risk myelodysplastic syndromes and po

    ... modifier azacitidine . In an expanded phase 1 trial, CC-486 demonstrated clinical and biological activity in patients with International Prognostic ...

    Research Article last updated 06/23/2016 - 10:17am.

  10. Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS)

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... Purpose:  The goal of this clinical research study is to compare how 2 different drugs, decitabine ...

    Clinical Trial last updated 05/14/2018 - 1:55pm.